Literature DB >> 26783137

The gonadotropin-releasing hormone system: Perspectives from reproduction to cancer (Review).

Arturo Aguilar-Rojas1, Marco Allan Pérez-Solis1, Guadalupe Maya-Núñez1.   

Abstract

Recently, an increasing amount of evidence indicates that human gonadotropin-releasing hormone (hGnRH) and its receptor (hGnRHR) are important regulatory components not only to the reproduction process but also in the regulation of some cancer cell functions such as cell proliferation, in both hormone-dependent and -independent types of tumors. The hGnRHR is a naturally misfolded protein that is retained mostly in the endoplasmic reticulum; however, this mechanism can be overcome by treatment with several pharmacoperones, therefore, increasing the amount of receptors in the cell membrane. In addition, several reports indicate that the expression level of hGnRHR in tumor cells is even lower than in pituitary or gonadotrope cells. The signal transduction pathways activated by hGnRH in both gonadotrope and different cancer cell types are described in the present review. We also discuss how the rescue of misfolded receptors in tumor cells could be a promising strategy for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26783137     DOI: 10.3892/ijo.2016.3346

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  10 in total

Review 1.  Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Drugs       Date:  2017-06       Impact factor: 9.546

2.  Antagonizing GnRH receptors: A temporary ADT salvage maneuver for prostate cancer patients experiencing PSA failure with GnRH agonist.

Authors:  Jehonathan Pinthus
Journal:  Can Urol Assoc J       Date:  2020-02       Impact factor: 1.862

3.  MicroRNA-200 family governs ovarian inclusion cyst formation and mode of ovarian cancer spread.

Authors:  Pui-Wah Choi; Wai Wing So; Junzheng Yang; Shubai Liu; Ka Kui Tong; Kin Ming Kwan; Jamie S-L Kwok; Stephen K W Tsui; Shu-Kay Ng; Karen H Hales; Dale B Hales; William R Welch; Christopher P Crum; Wing-Ping Fong; Ross S Berkowitz; Shu-Wing Ng
Journal:  Oncogene       Date:  2020-03-25       Impact factor: 9.867

4.  Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway.

Authors:  Ning Zhang; Junjun Qiu; Tingting Zheng; Xiaodan Zhang; Keqin Hua; Ying Zhang
Journal:  Oncol Rep       Date:  2017-12-15       Impact factor: 3.906

5.  Subclinical Lipopolysaccharide from Salmonella Enteritidis Induces Dysregulation of Bioactive Substances from Selected Brain Sections and Glands of Neuroendocrine Axes.

Authors:  Anita Mikołajczyk; Dagmara Złotkowska
Journal:  Toxins (Basel)       Date:  2019-02-02       Impact factor: 4.546

Review 6.  Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs.

Authors:  Maira Huerta-Reyes; Guadalupe Maya-Núñez; Marco Allán Pérez-Solis; Eunice López-Muñoz; Nancy Guillén; Jean-Christophe Olivo-Marin; Arturo Aguilar-Rojas
Journal:  Front Oncol       Date:  2019-10-01       Impact factor: 6.244

Review 7.  Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions.

Authors:  Fabrizio Fontana; Monica Marzagalli; Marina Montagnani Marelli; Michela Raimondi; Roberta M Moretti; Patrizia Limonta
Journal:  Int J Mol Sci       Date:  2020-12-14       Impact factor: 5.923

Review 8.  Dissecting the Hormonal Signaling Landscape in Castration-Resistant Prostate Cancer.

Authors:  Fabrizio Fontana; Patrizia Limonta
Journal:  Cells       Date:  2021-05-07       Impact factor: 6.600

9.  Apoptotic Effects of Drug Targeting Conjugates Containing Different GnRH Analogs on Colon Carcinoma Cells.

Authors:  Eszter Lajkó; Rózsa Hegedüs; Gábor Mező; László Kőhidai
Journal:  Int J Mol Sci       Date:  2019-09-08       Impact factor: 5.923

10.  Direct evidence on the efficacy of GnRH agonist in recurrent steroid cell tumor-not otherwise specified.

Authors:  Tadaharu Nakasone; Tomoko Nakamoto; Akiko Matsuzaki; Hiroshige Nakagami; Yoichi Aoki
Journal:  Gynecol Oncol Rep       Date:  2019-07-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.